Park Environment
   Home  >  About us  >  Park Environment
Based on the developmental timeframe of the biomedical science industry overseas and successful models of biomedical science parks, Taiwan should refer to a developmental model that focuses on clusters and introduce the concept of an SI2C one-stop shop. This will plant the seeds for the R&D of medical devices, while a clinical trial platform and the incubation of products that have large market potential will be offered. At the same time, the ICT design and production strengths from the nearby Hsinchu Science and Industrial Park will be utilized to effectively boost market competitiveness of these items. Consequently, the Biomedical Science and Product R&D Center, Hsinchu the Biomedical Science Park Incubation Center, and the Hsinchu Biomedical Science Park Hospital will help to bring treatment, research, industrial and lifestyle needs all under one umbrella. The park will display a new face in the development of biomedical science technology here and will realize the government's vision of forging a knowledge-based economy that boosts national competitiveness.


The Hsinchu Biomedical Science Park will be located on a 38.1 hectare plot of land in Zhubei City within blocks of the special development zone around the High Speed Railway's Hsinchu Station. The park will be about eight kilometers southwest of downturn Hsinchu and about three kilometers northwest is the Zhubei City Hall and the Hsinchu County Government Hall. County Route 120 runs along the north edge of the park and presently serves as the main transportation route. The Zhubei Station of the East-West Railway, the Sun Yat-sen Freeway and the Formosa Freeway flank the park, and the park can be reached in about 10 minutes after exiting the Formosa Freeway at the Zhulin interchange.

Status of the Park

  1. This project is one aspect of the infrastructure planned under the Industrial Innovation Corridor as part of the i-Taiwan 12 Infrastructure Projects. The government is promoting its Six Key Emerging Industries development strategy in reflection of the world trend towards energy conservation, carbon reduction, an aging society, and the rise of an innovation-driven economy. Biotechnology is one of these six industries, and efforts are being made to strengthen the ability to commercialize R&D successes and to create a biotech Supra-Incubator, helping to entice private capital into this sector. The park's three main centers will complement each other and enable the different arms to share R&D resources. Efforts are being made to attract renowned international players and research centers to the park, and to harness the strengths of the ICT industry in the nearby Hsinchu Science and Industrial Park, ultimately forming an industrial cluster. A key focus will be to establish innovative technology value and a platform to enhance value in the course of industrialization, serving to drive the development of Taiwan's biotechnology industry and creating a park to lead this initiative. This will be a benchmark project in the development of Taiwan's biotech sector.
  2. The Hsinchu Biomedical Science Park will be designated as a science and industrial park under the auspices of the Ministry of Science and Technology. Administrative management affairs and infrastructure-related issues will be handled by the Hsinchu Science Park Bureau in accordance with the Act for Establishment and Administration of Science Parks, as well as other enforcement rules and related measures.

R&D-related Facilities

This is a knowledge-, innovation- and incubation-oriented science park that will act as an incubator in the biomedical sciences industry. Aside from providing the normal functions of a park, this area will provide clinical trials, an R&D center, business seed planning, an innovative R&D network (R&D facilities and talent), clinical trial cooperation, and regulatory consulting services. The function and facilities of the overall park will cover hardware facilities, health care, talent, commerce and industry, and industrial services. Providing a business platform and a clinical trial network, while also encouraging the sharing of resources and the exchange of knowledge, will effectively reduce R&D and commercialization costs in a substantial manner and at the same time raise the success rate for biomedical science start-ups, thus ensuring the formation of this industry in Taiwan.

Functional Integration of R&D

The park will have three major centers, according to its target vision and function. The coordinated operation model of these three centers (as shown in Picture 3) aims to, on a vertical level, integrate successful innovation and R&D at the upstream, mid-stream and downstream levels and promote incubation, thereby developing the biomedical science industry. Horizontally, these three centers will create a complementary mechanism to foster a biomedical sciences R&D platform, integrate R&D talent and, and the flow of funding. This will enhance synergy, create an environment for Taiwan's biomedical science sector to take root, and ensure the formation and scale of this industry here.


The Hsinchu Biomedical Science Park Hospital will drive biomedical science R&D in the park, combining R&D, medical treatment, industry and lifestyle needs in the process. It will be both the instigator of R&D and the industry's development, and also the ultimate user of these achievements. It will drive research in response to clinical needs, and it will work in conjunction with the Biomedical Science Technology and Product R&D Center to implement basic research, after which R&D successes are industrialized and commercialized. The hospital will be the point where efficacy of related products is validated, and it will provide an avenue for product clinical trial and certification. This will boost the product success rate and help create the foundation for the industry's development.